Amicus Therapeutics Inc (FOLD)

Feb 22, 2025

Transcend Capital Advisors LLC Acquires 37,059 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Feb 22, 2025

Feb 21, 2025

Amicus Therapeutics files prospectus for stock sales By Investing.com - Investing.com Australia

Feb 21, 2025

Feb 21, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2024 Earnings Call Transcript - MSN

Feb 21, 2025

Feb 21, 2025

Amicus Therapeutics CEO Campbell Bradley sells $4,000 in stock - Investing.com India

Feb 21, 2025

Feb 21, 2025

Amicus Therapeutics files prospectus for stock sales - Investing.com India

Feb 21, 2025

Feb 21, 2025

Form 424B5 AMICUS THERAPEUTICS, - StreetInsider.com

Feb 21, 2025

Feb 21, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Stock Position Lifted by Rice Hall James & Associates LLC - MarketBeat

Feb 21, 2025

Feb 21, 2025

Cell and Gene Therapies in Rare Disorders Market to Skyrocket Across the 7MM During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.

Feb 21, 2025

Feb 21, 2025

Wells Fargo & Company Cuts Amicus Therapeutics (NASDAQ:FOLD) Price Target to $17.00 - MarketBeat

Feb 21, 2025

Feb 21, 2025

Needham & Company LLC Reaffirms Hold Rating for Amicus Therapeutics (NASDAQ:FOLD) - MarketBeat

Feb 21, 2025

Feb 21, 2025

Amicus Therapeutics (FOLD) Expected to Announce Earnings on Wednesday - MarketBeat

Feb 21, 2025

Feb 20, 2025

Insights Into Amicus Therapeutics (FOLD) Q4: Wall Street Projections for Key Metrics - MSN

Feb 20, 2025

Feb 20, 2025

Amicus Therapeutics (NASDAQ:FOLD) Shares Gap Down on Disappointing Earnings - MarketBeat

Feb 20, 2025

Feb 20, 2025

Compared to Estimates, Amicus Therapeutics (FOLD) Q4 Earnings: A Look at Key Metrics - Yahoo Finance

Feb 20, 2025

Feb 20, 2025

Amicus Therapeutics (NASDAQ:FOLD) Posts Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat

Feb 20, 2025

Feb 20, 2025

Amicus projects 17%-24% revenue growth in 2025, fueled by Fabry and Pompe therapies - MSN

Feb 20, 2025

Feb 20, 2025

Amicus Therapeutics Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Feb 20, 2025

Feb 20, 2025

Amicus Therapeutics: From Strong Growth to Exciting Future Projections - Jomfruland.net

Feb 20, 2025

Feb 19, 2025

Amicus Therapeutics Inc FOLD - Stockhouse Publishing

Feb 19, 2025

Feb 19, 2025

BofA cuts Amicus Therapeutics stock target to $14, keeps Buy rating - Investing.com Canada

Feb 19, 2025

Feb 19, 2025

AMICUS THERAPEUTICS, INC. SEC 10-K Report - TradingView

Feb 19, 2025

Feb 19, 2025

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term Shareholders to Contact the Firm - Milton Daily Standard

Feb 19, 2025

Feb 19, 2025

Amicus Therapeutics (FOLD) Q4 Earnings and Revenues Miss Estimates - Yahoo Finance

Feb 19, 2025

Feb 19, 2025

AMICUS THERAPEUTICS Earnings Results: $FOLD Reports Quarterly Earnings - Nasdaq

Feb 19, 2025

Feb 19, 2025

Amicus Therapeutics Turns To Q4 Profit; Product Sales Grow 30% - Nasdaq

Feb 19, 2025

Feb 19, 2025

Amicus Therapeutics' Q4 Non-GAAP Earnings, Net Product Revenue Rise -February 19, 2025 at 07:34 am EST - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Stock Position Lifted by Peregrine Capital Management LLC - MarketBeat

Feb 19, 2025

Feb 19, 2025

Amicus Therapeutics Reports Strong 2024 Financial Results and Positive Outlook for 2025 - TradingView

Feb 19, 2025

Feb 19, 2025

Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates - GlobeNewswire

Feb 19, 2025

Feb 18, 2025

Amicus Therapeutics stock hits 52-week low at $9.01 By Investing.com - Investing.com Nigeria

Feb 18, 2025

Feb 18, 2025

Amicus Therapeutics FY 2024 Earnings Preview - MSN

Feb 18, 2025

Feb 18, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Stock Position Trimmed by Fiera Capital Corp - MarketBeat

Feb 18, 2025

Feb 17, 2025

Kuehn Law Encourages Investors of Amicus Therapeutics, Inc. to Contact Law Firm - EIN News

Feb 17, 2025

Feb 16, 2025

Amicus Therapeutics (NASDAQ:FOLD) Upgraded to "Buy" at StockNews.com - MarketBeat

Feb 16, 2025

Feb 15, 2025

Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - MSN

Feb 15, 2025

Feb 15, 2025

Unfolding Amicus - RTTNews

Feb 15, 2025

Feb 13, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Feb 13, 2025

Feb 12, 2025

Analysts Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) PT at $16.88 - Defense World

Feb 12, 2025

Feb 11, 2025

abrdn plc Cuts Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Feb 11, 2025

Feb 10, 2025

Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025 - GlobeNewswire

Feb 10, 2025

Feb 10, 2025

Amicus Therapeutics to Host Conference Call for Full-Year 2024 Financial Results on February 19, 2025 - Nasdaq

Feb 10, 2025

Feb 10, 2025

Amicus Therapeutics (FOLD) Sets Critical 2024 Earnings ReviewKey Details for Rare Disease Investors - StockTitan

Feb 10, 2025

Feb 09, 2025

27,523 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Acquired by Tempus Wealth Planning LLC - MarketBeat

Feb 09, 2025